Velsera

We’re less than a week away from the ASHG 2024 conference in Denver! Velsera is excited to invite you to Booth 324, where we’re showcasing ARIA, our solution designed to help you uncover transformative insights, whether you're conducting population-scale studies or focused investigations. Start your day with a boost from our crafted caffeinated beverages and explore what ARIA and Seven Bridges Platform can do for your research. Here’s what you need to know about Velsera ARIA: 🌐 ARIA is a powerful, integrated data environment built to generate actionable insights from diverse data sources—including clinical, genetic, multimodal, and multi-omic data. 🔍 With a scalable, intuitive interface, ARIA allows you to harness real-world data (RWD) for precise biomarker discovery and target identification, accelerating discovery and decision-making. Join us to learn how Velsera can make your data work for you. We can’t wait to see you at ASHG Nov 6-8. Schedule time with us here: https://lnkd.in/gfw5EvuY #EraofVelsera #DrugDiscovery #Tradeshow #Genomics #PrecisionMedicine

What’s Holding Back Your NGS Reporting? As NGS testing evolves, so do the challenges labs face in delivering accurate and timely results. Keeping up with clinical guidelines, ensuring data accuracy, managing the growing complexity of assays, and integrating new technologies are just a few of the common hurdles. But with the right support, these challenges can become opportunities. Join our upcoming webinar on November 7th, Clinical Decision Support-based Reporting: The Power of a Comprehensive Curated Knowledgebase, to learn how clinical decision support can elevate your lab’s NGS reporting. Register here: https://lnkd.in/gY5FRqjS #EraofVelsera #NGS #ClinicalSupport #LabChallenges #ClinicalSupport

Unlock Advanced Nextflow Performance on the Seven Bridges Platform!  We’re excited to announce the latest enhancements to the Seven Bridges Platform, designed to drive significant performance and cost optimizations for your Nextflow pipelines. With advanced features like multi-instance execution, process instance hints, memoization (reuse) and elastic disk, you can substantially reduce cloud costs and accelerate large-scale data analyses while maintaining portability of your workflows. Curious how these advanced capabilities can impact your Nextflow workflows? The Velsera team of bioinformatics experts optimized the nf-core/rnaseq pipeline, cutting cloud costs by up to 66% compared to AWS Batch, while improving task duration and computational efficiency for large-scale data analysis. Want to learn more? Download our paper here to discover how our enhanced Nextflow and CWL capabilities can supercharge your workflow management and accelerate your research. https://lnkd.in/eGyudShQ Our team will be at the Nextflow Summit in Barcelona on October 31st! Stop by our poster presentation to chat with us and explore how we can optimize your workflows. #Nextflow #CWL #DataAnalysis #WorkflowOptimization #CloudComputing #Bioinformatics #Velsera #NextflowSummit #CostSavings #ResearchExcellence #SevenBridges 

In a field where precision is everything, the need for enhanced tools has never been greater. Standard approaches often fall short, leading to missed variants and incomplete data. Did you miss our recent webinar with Jack DiGiovanna on improving accuracy and efficiency by leveraging the Human Pangenome Reference? We explored how pangenome references are raising the bar by improving genomic accuracy, ensuring better sequencing alignment, and delivering significant efficiency gains—all while reducing computational costs and eliminating the need for expensive joint calling. Access the recording now to see how these advances can elevate the rigor and clinical utility of your work: https://lnkd.in/gJXTH738 #Genomics #EraofVelsera #DrugDiscovery #Webinar #BiomedicalResearch

Just In: Velsera’s Monthly Webinar was just announced, "Clinical Decision Support-based Reporting: The Power of a Comprehensive Curated Knowledgebase." As NGS assays grow in size and complexity, strong clinical decision support is more critical than ever to ensure labs deliver accurate, high-quality data to their patients. Learn how leveraging a comprehensive curated knowledgebase can elevate your reporting and enhance your lab’s capabilities. Date & Time: November 7th, 8 AM PST Spots are filling up fast, register now to secure yours! https://lnkd.in/gShKdr2q Be in the know & don’t miss out! #Eraofvelsera #knowledgebase #NGS #expandedreporting #CDS

Struggling with the limitations of standard genomic methods? If you're facing challenges with accuracy, high computational costs, or inefficiencies in variant calling, you're not alone. But there's a better way. It’s not too late to register for our webinar tomorrow! Don’t miss out on this opportunity to explore how leveraging a human pangenome reference can improve research accuracy and efficiency. Register now: https://lnkd.in/gWnAU4QX #EraofVelsera #DrugDiscovery #Webinar #Genomics

ASHG 2024 in Denver is almost here, and Velsera is thrilled to be a part of it! Join us at Booth 324, where we’ll be showcasing our latest innovations in precision genomics, bioinformatics, and solutions for research while solving your workflow solution challenges. Our team of experts is ready to connect, discuss, and explore how Velsera can help you unlock new insights in your research. Whether you’re attending in person or following along virtually, we’d love to hear from you. Who’s attending? Stop by Booth 324 for some coffee and snacks, and let’s chat! Meet with us here: https://lnkd.in/grT5s2Dt #ASHG2024 #Genomics #EraofVelsera #PrecisionGenomics

Missed the live panel? We've got you covered! 🎥 Get exclusive access to the recorded panel discussion by the VICC, featuring Andrew Bredemeyer and industry experts as they discuss the latest FDA ruling and its impact on the diagnostics landscape. Whether you're navigating regulatory challenges or just want to stay informed, this is a must-watch! Watch the recording now! https://lnkd.in/gSfScmsA Stay ahead of the regulatory curve—don’t miss out on this discussion! #EraofVelsera #FDAruling #LDT #VICC #precisionmedicine

Are you facing challenges with genomic accuracy and high computational costs in your current sequencing methods? Join us on October 24th at 11 AM EST as part of our monthly webinar series to hear Jack DiGiovanna talk about Improving Accuracy and Efficiency Leveraging a Human Pangenome Reference. Discover how technology is shaping the future of genomic research and analysis. Register Now: https://lnkd.in/gme2HP8i #DrugDiscovery #EraofVelsera #Genomic #Research

Validating comprehensive genomic profiling (CGP) assays on NGS platforms is no small feat. It is complex, time-consuming, and costly. It demands not only precision but also a deep understanding of assay limitations and how they align with your patient population’s clinical needs. But with the right planning and expertise, you can streamline the process and improve clinical outcomes. At Velsera, we help labs tackle these challenges head-on, offering expert support in planning, analytical and clinical performance evaluations, and comprehensive documentation. From our experience, labs with higher sequencing capacity and NGS experience saw reduced validation times—yet all achieved robust analytical performance through controlled workflows and rigorous quality control. Curious to learn more? Download our latest poster, https://lnkd.in/gEXhzDAe featuring real-world insights from labs that have completed CGP validations, and see how Velsera is redefining what’s possible in NGS assay validation. Ready to optimize your validation journey? #EraofVelsera #precisionmedicine #CGP #NGS #validation